Clinical Trials Browser

Completed × Fenretinide × Clear all

NCT00646230 2026-04-14

IV Fenretinide

Phase 1 Completed

Neuroblastoma

NCT00003601 2023-06-18

Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome

Phase 2 Completed

Melanoma

NCT00004154 2018-11-08

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00006471 2018-11-01

Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00003075 2018-10-24

Fenretinide in Treating Patients With Cervical Neoplasia

Phase 3 Completed

GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00006080 2018-06-27

Fenretinide in Treating Patients With Recurrent Malignant Glioma

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00104923 2017-07-19

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

Phase 1 Completed

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis

NCT00080899 2015-03-06

Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Phase 2 Completed

23 enrolled 3 charts

Prostatic Neoplasms

NCT00003250 2014-04-11

Fenretinide in Treating Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00053326 2013-10-08

Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma

Phase 2 Completed

Neuroblastoma

NCT00387504 2013-09-12

Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00077402 2013-05-15

Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00004161 2013-04-12

Fenretinide in Treating Patients With Leukoplakia of the Mouth

Phase 2 Completed

Head and Neck Neoplasms, Mouth Neoplasms

NCT00011973 2013-04-05

Chemotherapy in Treating Patients With Advanced Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00026091 2013-03-25

Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial

NCT00009971 2013-02-11

Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

Phase 2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00003191 2013-02-07

Fenretinide in Treating Children With Solid Tumors

Phase 1 Completed

Neuroblastoma

NCT00003099 2012-07-30

Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00002646 2012-01-05

Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT00005819 2010-06-11

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00098800 2010-03-24

Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries

Phase NA Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00001378 2008-03-04

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

Phase 1 Completed

Breast Neoplasms, Camurati-Engelmann Syndrome